Table 2 Indication for ECLS support in the Transport group
From: ECLS supported transport of ICU patients: does out-of -house implantation impact survival?
Indication for ECMO (transport only) | total | v-v | v-a | p |
|---|---|---|---|---|
Total | 243 | 114 | 129 | |
Pneumonia | 102 (42) | 89 | 11 | p < 0.001 |
Influenza A | 18 (7) | 16 | 2 | p < 0.001 |
ARDS | 138 (57) | 118 | 16 | p < 0.001 |
Lungfibrosis | 3 (1) | 2 | 1 | p = 0.577 |
Pulmonary hypertension | 8 (3) | 2 | 6 | p = 0.84 |
Cystic fibrosis | 4 (2) | 4 | 0 | p = 0.091 |
Lung embolia | 11 (5) | 0 | 11 | p < 0.001 |
PMR/VSD/ASD | 10 (4) | 2 | 8 | p = 0.024 |
Myocardial infarction (NSTEMI, STEMI) | 35 (14) | 1 | 34 | p < 0.001 |
DCM | 15 (6) | 0 | 14 | p < 0.001 |
Myocarditis | 11 (5) | 0 | 11 | p < 0.001 |
Peripartum cardiomyopathy | 3 (1) | 0 | 3 | p = 0.089 |
Polytrauma | 8 (3) | 8 | 0 | p = 0.008 |
Sepsis | 0 | 0 | 0 | |
Post DLTX | 0 | 0 | 0 | |
Postcardiectomie | 1 (0.4) | 0 | 0 | p = 0.285 |
Burn | 0 | 0 | p = 0.362 | |
post HTX | 4 (2) | 0 | 0 | |
Cardiac failure after VAD | 1 (0.4) | 0 | 1 | p = 0.449 |
Postcardiotomie | 1 (0.4) | 0 | 1 | P = 0.449 |
Others | 9 (4) | 6 | 3 | p = 0.362 |